Navigation Links
Mach One Corporation Announces Completion of Final Tests Prior to Full Scale Production
Date:4/3/2008

WEST BEND, Wis., April 3, 2008 /PRNewswire-FirstCall/ -- Mach One Corporation, http://www.machonecorp.com, (Pink Sheets: MNCN) announces that the final tests prior to large scale manufacturing of its ImmunoGam(TM) colostrum replacement product were completed last week.

"A highly qualified scientist from BioQual spent a week with us in our Belgium, Wisconsin facility completing a technology transfer and memorializing the protocols for manufacture of our flagship product ImmunoGam(TM)" stated Monte Tobin, President of Mach One. "The BioQual scientist couldn't believe the progress we have made in taking their original concept of colostrum replacement for the equine industry and adapting it through our own science to the dairy industry with ImmunoGam(TM). These newly designed protocols should revolutionize the colostrum replacement industry and in keeping with our corporate philosophy we will be 'building a better herd, one calf at a time(TM)'."

"ImmunoGam (TM) is a product that could be used for the nine million dairy calves born each year," continued Tobin, "This replacement product can be used as a time saving management tool for large dairies that have as many as 15 to 50 calves being born each day throughout a year. We see this as a great opportunity to strengthen the health of dairy cattle as a whole and to allow the dairyman to see full yields from his herd. Production in bulk should start within the next 10 days."

About Mach One Corporation

Through its wholly-owned subsidiary VDx, Inc. (http://www.vdxinc.com), the company will manufacture and sell Immunogam (TM), a colostrums replacement, supplement and prophylactic, in sterile powder form, which can be administered orally or intravenously. VDx is also further developing a proprietary procedure to allow for large scale manufacturing of colostral replacement products for market that includes an added ingredient for elimination of mastitis and Johnnes disease.

The IgG replacement market is estimated at 1.1 billion dollars per year.

Safe Harbor Statement

This press release contains forward-looking information. Readers are cautioned not to place undue reliance on any such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties which are disclosed in the Company's SEC reports. These risks and uncertainties could cause actual results to differ materially from those currently anticipated or projected.


'/>"/>
SOURCE Mach One Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Brooke Franchise Corporation Announces Selected July Results
3. MedThink Communications Retained by NanoBio Corporation
4. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
5. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
6. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
7. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
8. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
9. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
10. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
11. AGA Medical Corporation Receives Approval for the AMPLATZER Muscular Ventricular Septal Defect Occluder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... February 21, 2017 , ... Individuals who have been diagnosed ... surgery, treatment, therapy and management. Regular exercise in proper environments has been shown ... their diseases. On February 23, 2017, 1:00-2:00 p.m. E.S.T., a dynamic HydroWorx ...
(Date:2/21/2017)... Ga. (PRWEB) , ... February 21, 2017 , ... Support ... To simplify the secure exchange of data across industry solutions, Fogo Data Centers ... the power of community. A healthy community is one in which all systems ...
(Date:2/21/2017)... Doylestown, Pa. (PRWEB) , ... ... ... leading provider of technology-enabled clinical trial solutions, today announced the further expansion ... types of applications they can leverage as part of Bioclinica’s extensive and ...
(Date:2/21/2017)... GA (PRWEB) , ... February 21, 2017 , ... ... announced the acquisition of the predictive analytic firm Predixion’s Healthcare IT practice. Predixion, ... investment and is backed by giants including Accenture, GE Ventures, and ...
(Date:2/21/2017)... ... February 21, 2017 , ... One ... untreated despite the medical, mental health, and financial consequences of inaction. On March ... take action if they have concerns about their hearing. , Effective treatment in ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... Feb. 21, 2017 Research and Markets has announced ... - 2016" report to their offering. ... The latest research Liver Cirrhosis Drugs Price Analysis and ... Liver Cirrhosis market. The research answers the following questions: ... and their clinical attributes? How are they positioned in the Global Liver ...
(Date:2/20/2017)... Feb. 20, 2017 EU5 Magnetic Resonance Imaging (MRI) Systems ... ... Resonance Imaging (MRI) Systems Market Outlook to 2022", provides key market ... report provides value, in millions of US dollars, volume (in units) ... and 1.5T MRI Systems. The report also provides ...
(Date:2/20/2017)... , Feb. 20, 2017  This Report analyzes the worldwide ... Dosage Forms: Injectables, Solid Dosage Forms, and Liquid & Semi-solid Dosage ... Canada , Japan , ... World. Read the full report: http://www.reportlinker.com/p04707109-summary/view-report.html ... Annual estimates ...
Breaking Medicine Technology: